EU drug regulator EMA expects Johnson & Johnson (JNJ) to file for approval of its COVID-19 vaccine in the next few days - Reuters
- Dow hits milestone, S&P breaks record high on tech rally
- Thermo Fisher Scientific (TMO) to Acquire PPD, Inc. (PPD) for $47.50/sh, $17.4 Billion
- U.S. retail sales post largest gain in 10 months; weekly jobless claims fall
- The Stock Market is Almost 'Completely Broken' - Einhorn
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
EU drug regulator EMA expects Johnson & Johnson (NYSE: JNJ) to file for approval of its COVID-19 vaccine in the next few days - Reuters
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CDC Panel Tentatively Set to Met Late Next Week on J&J (JNJ) Shot - Bloomberg
- Coinbase (COIN) Adds to Gains
- Fauci says he believes J&J vaccine will 'get back on track soon'